Top Markets
#1 MowCat MowCat +49.00%
#2 Velvet Velvet +28.16%
#3 Derive Derive +22.75%
#4 Audiera Audiera +19.65%
#5 Geodnet Geodnet +16.26%
#6 Biconomy Biconomy +16.21%
#7 aPriori aPriori +15.56%
#8 Quack AI Quack AI +14.82%
#9 Cross Cross +13.93%
#10 The Bitcoin Bull The Bitcoin Bull +10.01%
Coin of the day
MowCat MowCat
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Tissue Repair Ltd Tissue Repair Ltd

Tissue Repair Ltd

TRP
Classificação em ações #35634
Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical... Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures. Its product pipeline features TR-987 and a suite of innovative dressings and matrices, including the proprietary Glucoprime technology. These are specifically engineered to address challenging conditions such as chronic wounds, burns, and other complex dermal injuries. Additionally, TR Pro+ is being developed for post-procedure care after minimally invasive aesthetic treatments. Beyond these core programs, Tissue Repair is also exploring applications in animal health, novel bandage and scaffold technologies, and various other therapeutic areas. The company was founded in 2012 and operates from its headquarters in Sydney, Australia.
Preço da ação
$0.05994921
Última sincronização: 2026-08-13
Valor de mercado
$3.62M
Variação (1 dia)
-1.16%
Variação (1 ano)
-66.49%
País
AU
Negociar Tissue Repair Ltd (TRP)

Categoria

Healthcare
Receita da Tissue Repair Ltd (TRP)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Tissue Repair Ltd, a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Tissue Repair Ltd de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE